Ovarian cancer in situ: a case report
https://doi.org/10.17650/1994-4098-2024-20-3-95-98
Abstract
In most cases, ovarian cancer is diagnosed at advanced stages, leading to a poor prognosis. Currently, there is no effective screening for ovarian cancer, so detecting it in the early stages is a fairly successful case.
Keywords
About the Authors
A. N. TuromshaRussian Federation
Alesya Nikolaevna Turomsha
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Competing Interests:
The authors declare no conflict of interest
A. E. Protasova
Russian Federation
Build. 2, 4 Ilyushina St., Saint Petersburg 196634; 7—9 Universitetskaya Naberezhnaya, Saint Petersburg 199034; 2 Akkuratova St., Saint Petersburg 197341
Competing Interests:
The authors declare no conflict of interest
G. A. Raskin
Russian Federation
7—9 Universitetskaya Naberezhnaya, Saint Petersburg 199034; Build. 3A, 2 Yesenina St., Saint Petersburg 194354
Competing Interests:
The authors declare no conflict of interest
E. D. Kravtsova
Russian Federation
Build. 3A, 2 Yesenina St., Saint Petersburg 194354
Competing Interests:
The authors declare no conflict of interest
A. L. Andreev
Russian Federation
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Competing Interests:
The authors declare no conflict of interest
L. V. Strakh
Russian Federation
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Competing Interests:
The authors declare no conflict of interest
M. Yu. Sheremet
Russian Federation
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Competing Interests:
The authors declare no conflict of interest
References
1. Situtation with cancer care in Russia in 2021. Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow Oncology Research Institute - a branch of the National Medical Research Radiological Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.).
2. National Cancer Institute SEER Program. Cancer Stat Facts: Ovarian Cancer. Available at: https://seer.cancer.gov/statfacts/html/ovary.html.
3. ACOG Committee Opinion No. 755: Well-Woman Visit. Obstet Gynecol 2018;132(4):e181-6. DOI: 10.1097/AOG.0000000000002897
4. Andrews L., Mutch D.G. Hereditary ovarian cancer and risk reduction. Best Pract Res Clin Obstet Gynaecol 2017;41:31-48. DOI: 10.1016/j.bpobgyn.2016.10.017
5. Daly M.B., Pal T., Berry M.P. et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20216;19(1):77-102. DOI: 10.6004/jnccn.2021.0001
6. Gonzalez-Martm A., Harter P., Leary A. et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34(10):833-48. DOI: 10.1016/j.annonc.2023.07.011
7. Frank G.A., Moskvina L.V., Andreeva Yu.Yu. A new classification of ovarian tumors. Arkhiv Patologii = Pathology Archive 2015;77(4):40-50. (In Russ.). DOI: 10.17116/patol201577440-50
8. WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th edn. Lyon: International Agency for Research on Cancer, 2020. Available at: https://tumourclassification.iarc.who.int.
9. Babaier A., Ghatage P. Mucinous cancer of the ovary: Overview and current status. Diagnostics (Basel) 2020;10(1):52. DOI: 10.3390/diagnostics10010052
10. Inoue K., Tsubamoto H., Hao H. et al. Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report. Gynecol Oncol Case Rep 2013;5:61-3. DOI: 10.1016/j.gynor.2013.05.002
Review
For citations:
Turomsha A.N., Protasova A.E., Raskin G.A., Kravtsova E.D., Andreev A.L., Strakh L.V., Sheremet M.Yu. Ovarian cancer in situ: a case report. Tumors of female reproductive system. 2024;20(3):95-98. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-3-95-98